Review



wt5260 083850 transposase 837  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    ATCC wt5260 083850 transposase 837
    Wt5260 083850 Transposase 837, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/200454/Nais+inornata+Kohlmeyer/pmc09045324__spectrum02434___21_supp_1_seq11-24-47-86
    Average 91 stars, based on 1 article reviews
    wt5260 083850 transposase 837 - by Bioz Stars, 2026-10
    91/100 stars

    Images

    Related Articles

    Extraction:

    Article Title: Reference-Grade Genome and Large Linear Plasmid of Streptomyces rimosus : Pushing the Limits of Nanopore Sequencing
    Article Snippet: Cluster No. in ATCC 10970 Type From To Most similar known biosynthetic gene cluster (percent of similarity) Location in M4018 plasmid Location in R6 plasmid 1 Type I PKS 143989 163050 kanamycin (1 %) 144008 163069 143937 1629 84 2 NRPS 215829 230795 NA 215875 230814 / / Table S8: Coding sequences at regions where contigs are not connected with eachother in the mapping of genome assembly GCF_000716745.1 to our GCF_006229535.1 plasmid sequence.

    Produced:

    Article Title: Reference-Grade Genome and Large Linear Plasmid of Streptomyces rimosus : Pushing the Limits of Nanopore Sequencing
    Article Snippet: Cluster No. in ATCC 10970 Type From To Most similar known biosynthetic gene cluster (percent of similarity) Location in M4018 plasmid Location in R6 plasmid 1 Type I PKS 143989 163050 kanamycin (1 %) 144008 163069 143937 1629 84 2 NRPS 215829 230795 NA 215875 230814 / / Table S8: Coding sequences at regions where contigs are not connected with eachother in the mapping of genome assembly GCF_000716745.1 to our GCF_006229535.1 plasmid sequence.



    Similar Products

    91
    ATCC wt5260 083850 transposase 837
    Wt5260 083850 Transposase 837, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/200454/Nais+inornata+Kohlmeyer/pmc09045324__spectrum02434___21_supp_1_seq11-24-47-86
    Average 91 stars, based on 1 article reviews
    wt5260 083850 transposase 837 - by Bioz Stars, 2026-10
    91/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology kainic acid
    Kainic Acid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/200454/Kainic+acid/bio_rxiv__2025__10__17__683151-175-11-14
    Average 92 stars, based on 1 article reviews
    kainic acid - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology drugs kainic acid
    Drugs Kainic Acid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/200454/Kainic+acid/pmc09899633-74-0-4
    Average 92 stars, based on 1 article reviews
    drugs kainic acid - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology post kainic acid induced status epilepticus
    Figure 3 RTA 408 rescues total glutathione and ATP levels following <t>kainic</t> acid-induces status <t>epilepticus</t> in vivo. (A) Total (oxidized and reduced forms of glutathione) were measured in the cortex and hippocampus of sham rats (sham; n = 7 for cortex and n = 6 for hippocampus), and from treated rats 7 days following kainic acid-induced status epilepticus (2 h), followed by vehicle (10% DMSO/saline kainic acid + vehicle; n = 5), RTA 408 groups at doses: 17.5 mg/kg once daily for 3 days (kainic acid + RTA 17.5; n = 6), 25 mg/kg once daily for 3 days (kainic acid + RTA 25; n = 5) and 50 mg/kg once daily for 2 days (kainic acid + RTA 50; n = 6). (B) ATP levels measured in the same animals (sham; n = 6), vehicle (kainic acid + vehicle; n = 5), RTA 408 17.5 mg/kg once daily for 3 days (kainic acid + RTA 17.5; n = 5), RTA 408 25 mg/kg once daily for 3 days (kainic acid + RTA 25; n = 5) and RTA 408 50 mg/kg once daily for 2 days (kainic acid + RTA 50; n = 6). Data are expressed as mean SEM. *P 5 0.05, **P 5 0.01 and ***P 5 0.001 versus kainic acid group, by one-way ANOVA with Bonferroni post hoc test. In A, cortex: F(4,24) = 18.197, P 5 0.001; hippocampus: F(4,22) = 101.409, P 5 0.001; In B, cortex: F(4,21) = 11.738, P 5 0.001; hippocampus: F(4,21) = 20.262, P 5 0.001. KA = kainic acid.
    Post Kainic Acid Induced Status Epilepticus, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/200454/Kainic+acid/pm29538645-155-5-30
    Average 92 stars, based on 1 article reviews
    post kainic acid induced status epilepticus - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology référence catalogue
    Figure 3 RTA 408 rescues total glutathione and ATP levels following <t>kainic</t> acid-induces status <t>epilepticus</t> in vivo. (A) Total (oxidized and reduced forms of glutathione) were measured in the cortex and hippocampus of sham rats (sham; n = 7 for cortex and n = 6 for hippocampus), and from treated rats 7 days following kainic acid-induced status epilepticus (2 h), followed by vehicle (10% DMSO/saline kainic acid + vehicle; n = 5), RTA 408 groups at doses: 17.5 mg/kg once daily for 3 days (kainic acid + RTA 17.5; n = 6), 25 mg/kg once daily for 3 days (kainic acid + RTA 25; n = 5) and 50 mg/kg once daily for 2 days (kainic acid + RTA 50; n = 6). (B) ATP levels measured in the same animals (sham; n = 6), vehicle (kainic acid + vehicle; n = 5), RTA 408 17.5 mg/kg once daily for 3 days (kainic acid + RTA 17.5; n = 5), RTA 408 25 mg/kg once daily for 3 days (kainic acid + RTA 25; n = 5) and RTA 408 50 mg/kg once daily for 2 days (kainic acid + RTA 50; n = 6). Data are expressed as mean SEM. *P 5 0.05, **P 5 0.01 and ***P 5 0.001 versus kainic acid group, by one-way ANOVA with Bonferroni post hoc test. In A, cortex: F(4,24) = 18.197, P 5 0.001; hippocampus: F(4,22) = 101.409, P 5 0.001; In B, cortex: F(4,21) = 11.738, P 5 0.001; hippocampus: F(4,21) = 20.262, P 5 0.001. KA = kainic acid.
    Référence Catalogue, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/200454/Kainic+acid/pm30089219-74-18-42
    Average 92 stars, based on 1 article reviews
    référence catalogue - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology sc 200454a
    Figure 3 RTA 408 rescues total glutathione and ATP levels following <t>kainic</t> acid-induces status <t>epilepticus</t> in vivo. (A) Total (oxidized and reduced forms of glutathione) were measured in the cortex and hippocampus of sham rats (sham; n = 7 for cortex and n = 6 for hippocampus), and from treated rats 7 days following kainic acid-induced status epilepticus (2 h), followed by vehicle (10% DMSO/saline kainic acid + vehicle; n = 5), RTA 408 groups at doses: 17.5 mg/kg once daily for 3 days (kainic acid + RTA 17.5; n = 6), 25 mg/kg once daily for 3 days (kainic acid + RTA 25; n = 5) and 50 mg/kg once daily for 2 days (kainic acid + RTA 50; n = 6). (B) ATP levels measured in the same animals (sham; n = 6), vehicle (kainic acid + vehicle; n = 5), RTA 408 17.5 mg/kg once daily for 3 days (kainic acid + RTA 17.5; n = 5), RTA 408 25 mg/kg once daily for 3 days (kainic acid + RTA 25; n = 5) and RTA 408 50 mg/kg once daily for 2 days (kainic acid + RTA 50; n = 6). Data are expressed as mean SEM. *P 5 0.05, **P 5 0.01 and ***P 5 0.001 versus kainic acid group, by one-way ANOVA with Bonferroni post hoc test. In A, cortex: F(4,24) = 18.197, P 5 0.001; hippocampus: F(4,22) = 101.409, P 5 0.001; In B, cortex: F(4,21) = 11.738, P 5 0.001; hippocampus: F(4,21) = 20.262, P 5 0.001. KA = kainic acid.
    Sc 200454a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/200454/Kainic+acid/pm30089219-74-21-42
    Average 92 stars, based on 1 article reviews
    sc 200454a - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology kainic acid treatment
    ( a ) Representative spinal cord sections from therapeutically treated EAE mice stained for NFH (red), SMI-32 (green), scale bar = 50 μm. ( b ) Quantification of SMI-32 signal intensity relative to NFH from. ( c ) Representative EM images from three-dimensional reconstructed blocks showing degenerating axons from vehicle-treated EAE mice, and sections from KPT-350 mice depicting intact axons with no myelin, and intact axons with split myelin lamellae, (* indicates intra-lamellar myelin debris); scale bar = 1.0 μm. ( d ) Quantification from 3D-EM data sets of axons undergoing Wallerian degeneration normalized to total axons. ( e ) Quantification from 3D-EM data sets of total axons per mm 2 . ( f ) Pie graphs representing the relative degree of cytoskeletal damage in axons from vehicle, KPT-276 or KPT-350 treated mice. Healthy axons were defined by 100% cytoskeletal arrangement. Axonal damage was then quantified based on the percentage of cytoskeletal disruption with 25% or 50% disruption as indicated by an absent, fragmented or aberrantly oriented cytoskeleton; 100% disruption when only a disrupted, or flocculent cytoskeleton were detected. At least 200 axons were counted per treatment group and at least n = 2 mice per group; scale bar = 0.1 μm. ( g ) Schematic diagram of in vivo <t>kainic</t> <t>acid-induced</t> neurotoxicity in mice. Representative confocal images of CA3 region of in vivo mouse hippocampus from mice treated with either vehicle or KPT-350 (7.5 mg/kg) for 1 hr followed by injection with kainic acid (2 mg/kg) for 18 hr. Coronal brain slices of hippocampus were stained with NFH (red), SMI-32 (green), DAPI (blue); scale bar = 100 μm. ( h ) Quantification of SMI-32 intensity. Values represent mean pixel intensity ± SEM of n=2 animals per group, from two independent experiments. ( i ) Representative IBA1 + (green) stained sections of hippocampus, sections were counterstained with DAPI (blue); scale bar = 100 μm. ( j ) Quantification of ( i ). Bar graphs represent mean ± SEM. Statistical differences in: ( b ), ( h ), and ( j ) were determined using one-way ANOVA with Tukey's correction (**p < 0.01 vs. vehicle, ***p < 0.001 vs kainic acid); ( d ), ( e ) Kruskall-Wallis tests with Dunn's correction (*p < 0.05 vs. vehicle-treated controls, n=3 animals per group).
    Kainic Acid Treatment, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/200454/Kainic+acid/pmc04522902-230-29-45
    Average 92 stars, based on 1 article reviews
    kainic acid treatment - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    Image Search Results


    Figure 3 RTA 408 rescues total glutathione and ATP levels following kainic acid-induces status epilepticus in vivo. (A) Total (oxidized and reduced forms of glutathione) were measured in the cortex and hippocampus of sham rats (sham; n = 7 for cortex and n = 6 for hippocampus), and from treated rats 7 days following kainic acid-induced status epilepticus (2 h), followed by vehicle (10% DMSO/saline kainic acid + vehicle; n = 5), RTA 408 groups at doses: 17.5 mg/kg once daily for 3 days (kainic acid + RTA 17.5; n = 6), 25 mg/kg once daily for 3 days (kainic acid + RTA 25; n = 5) and 50 mg/kg once daily for 2 days (kainic acid + RTA 50; n = 6). (B) ATP levels measured in the same animals (sham; n = 6), vehicle (kainic acid + vehicle; n = 5), RTA 408 17.5 mg/kg once daily for 3 days (kainic acid + RTA 17.5; n = 5), RTA 408 25 mg/kg once daily for 3 days (kainic acid + RTA 25; n = 5) and RTA 408 50 mg/kg once daily for 2 days (kainic acid + RTA 50; n = 6). Data are expressed as mean SEM. *P 5 0.05, **P 5 0.01 and ***P 5 0.001 versus kainic acid group, by one-way ANOVA with Bonferroni post hoc test. In A, cortex: F(4,24) = 18.197, P 5 0.001; hippocampus: F(4,22) = 101.409, P 5 0.001; In B, cortex: F(4,21) = 11.738, P 5 0.001; hippocampus: F(4,21) = 20.262, P 5 0.001. KA = kainic acid.

    Journal: Brain : a journal of neurology

    Article Title: KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy.

    doi: 10.1093/brain/awy071

    Figure Lengend Snippet: Figure 3 RTA 408 rescues total glutathione and ATP levels following kainic acid-induces status epilepticus in vivo. (A) Total (oxidized and reduced forms of glutathione) were measured in the cortex and hippocampus of sham rats (sham; n = 7 for cortex and n = 6 for hippocampus), and from treated rats 7 days following kainic acid-induced status epilepticus (2 h), followed by vehicle (10% DMSO/saline kainic acid + vehicle; n = 5), RTA 408 groups at doses: 17.5 mg/kg once daily for 3 days (kainic acid + RTA 17.5; n = 6), 25 mg/kg once daily for 3 days (kainic acid + RTA 25; n = 5) and 50 mg/kg once daily for 2 days (kainic acid + RTA 50; n = 6). (B) ATP levels measured in the same animals (sham; n = 6), vehicle (kainic acid + vehicle; n = 5), RTA 408 17.5 mg/kg once daily for 3 days (kainic acid + RTA 17.5; n = 5), RTA 408 25 mg/kg once daily for 3 days (kainic acid + RTA 25; n = 5) and RTA 408 50 mg/kg once daily for 2 days (kainic acid + RTA 50; n = 6). Data are expressed as mean SEM. *P 5 0.05, **P 5 0.01 and ***P 5 0.001 versus kainic acid group, by one-way ANOVA with Bonferroni post hoc test. In A, cortex: F(4,24) = 18.197, P 5 0.001; hippocampus: F(4,22) = 101.409, P 5 0.001; In B, cortex: F(4,21) = 11.738, P 5 0.001; hippocampus: F(4,21) = 20.262, P 5 0.001. KA = kainic acid.

    Article Snippet: One week or 15 weeks post kainic acid-induced status epilepticus, rats were perfused transcardially under terminal anaesthesia (pentobarbital sodium) with PBS (8 IU/ml), followed by 4% paraformaldehyde (PFA) in PBS (Santa Cruz Biotechnology).

    Techniques: In Vivo, Saline

    Figure 4 RTA 408 prevents neuronal cell death following kainic acid-induced status epilepticus in rats. (A) Representative images for CA1, CA3 and hilus of coronal sections from vehicle (10% DMSO/saline) treated and RTA 408 treated rats 15 weeks after status epilepticus (SE). Scale bar = 100 mM. (B–G) Cell densities in CA1, CA3 and hilus of sham (n = 6), and vehicle (n = 5) and RTA 408 (25 mg/kg/day for 3 days; n = 5) treated rats 1 week (B–D) and 15 weeks (E–G); in sham (n = 6), vehicle (n = 7), RTA 408 (25 mg/kg/day for 1 day; n = 5) and RTA 408 (25 mg/kg/day for 3 days; n = 7) following 2 h kainic acid induced status epilepticus. Data are expressed as mean SEM numbers of animals. *P 5 0.05, **P 5 0.01 and ***P 5 0.001 compared to vehicle group by one-way ANOVA followed by Bonferroni post hoc test. (B) F(2,13) = 2.806, P = 0.097; (C) F(2,13) = 9.220, P = 0.003; (D) F(2,13) = 42.138, P 5 0.001; (E) F(2,13) = 20.536, P 5 0.001; (F) F(2,13) = 10.236, P 5 0.001; (G) F(2,13) = 24.550, P 5 0.001.

    Journal: Brain : a journal of neurology

    Article Title: KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy.

    doi: 10.1093/brain/awy071

    Figure Lengend Snippet: Figure 4 RTA 408 prevents neuronal cell death following kainic acid-induced status epilepticus in rats. (A) Representative images for CA1, CA3 and hilus of coronal sections from vehicle (10% DMSO/saline) treated and RTA 408 treated rats 15 weeks after status epilepticus (SE). Scale bar = 100 mM. (B–G) Cell densities in CA1, CA3 and hilus of sham (n = 6), and vehicle (n = 5) and RTA 408 (25 mg/kg/day for 3 days; n = 5) treated rats 1 week (B–D) and 15 weeks (E–G); in sham (n = 6), vehicle (n = 7), RTA 408 (25 mg/kg/day for 1 day; n = 5) and RTA 408 (25 mg/kg/day for 3 days; n = 7) following 2 h kainic acid induced status epilepticus. Data are expressed as mean SEM numbers of animals. *P 5 0.05, **P 5 0.01 and ***P 5 0.001 compared to vehicle group by one-way ANOVA followed by Bonferroni post hoc test. (B) F(2,13) = 2.806, P = 0.097; (C) F(2,13) = 9.220, P = 0.003; (D) F(2,13) = 42.138, P 5 0.001; (E) F(2,13) = 20.536, P 5 0.001; (F) F(2,13) = 10.236, P 5 0.001; (G) F(2,13) = 24.550, P 5 0.001.

    Article Snippet: One week or 15 weeks post kainic acid-induced status epilepticus, rats were perfused transcardially under terminal anaesthesia (pentobarbital sodium) with PBS (8 IU/ml), followed by 4% paraformaldehyde (PFA) in PBS (Santa Cruz Biotechnology).

    Techniques: Saline

    Figure 5 RTA 408 modifies seizure progression. (A) EEG sample traces recorded for status epilepticus (SE): an asterisk indicates the beginning of status epilepticus whereas an arrow indicates termination with diazepam. (B) Typical EEG example of a spontaneous seizure post status epilepticus, expanded in the right panel. Note the rhythmical high frequency discharges at the beginning of the seizure (2) when compared to baseline (1). This rhythmic fast activity increases in amplitude (3) and decreases in frequency (4) towards the end of the seizure thus fulfilling the criteria for EEG seizure activity. (C and D) Bar charts of mean frequency (SEM) of electrographically recorded seizures following kainic acid induced status epilepticus for control rats, treated with vehicle (10% DMSO/saline) once daily for 3 days (n = 9) and RTA 408-treated rats (RTA 408 25 mg/kg once daily for 3 days; n = 9) 1–12 weeks [C; F(1,192) = 5.828, P 5 0.05] and 13–15 weeks following the first spontaneous seizure [D; F(1,18) = 10.163, P 5 0.01]; animal numbers in D: n = 4 for both groups. *P 5 0.05, **P 5 0.01 and ***P 5 0.001 by generalized log-linear mixed model followed by sequential Bonferroni post hoc test. (E) Probability distribution illustrating the probability of 0–10 seizures/day for each individual vehicle (n = 9) and RTA 408-treated rat (n = 9). (F) Bar chart summarizing mean SEM seizure probability across time; **P 5 0.01 probabilities of seizure free days were compared using Mann-Whitney U-test. (G) Seizure duration distribution for the same animals as in C, demonstrating no significant difference between vehicle or RTA408 treated animals. KA = kainic acid.

    Journal: Brain : a journal of neurology

    Article Title: KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy.

    doi: 10.1093/brain/awy071

    Figure Lengend Snippet: Figure 5 RTA 408 modifies seizure progression. (A) EEG sample traces recorded for status epilepticus (SE): an asterisk indicates the beginning of status epilepticus whereas an arrow indicates termination with diazepam. (B) Typical EEG example of a spontaneous seizure post status epilepticus, expanded in the right panel. Note the rhythmical high frequency discharges at the beginning of the seizure (2) when compared to baseline (1). This rhythmic fast activity increases in amplitude (3) and decreases in frequency (4) towards the end of the seizure thus fulfilling the criteria for EEG seizure activity. (C and D) Bar charts of mean frequency (SEM) of electrographically recorded seizures following kainic acid induced status epilepticus for control rats, treated with vehicle (10% DMSO/saline) once daily for 3 days (n = 9) and RTA 408-treated rats (RTA 408 25 mg/kg once daily for 3 days; n = 9) 1–12 weeks [C; F(1,192) = 5.828, P 5 0.05] and 13–15 weeks following the first spontaneous seizure [D; F(1,18) = 10.163, P 5 0.01]; animal numbers in D: n = 4 for both groups. *P 5 0.05, **P 5 0.01 and ***P 5 0.001 by generalized log-linear mixed model followed by sequential Bonferroni post hoc test. (E) Probability distribution illustrating the probability of 0–10 seizures/day for each individual vehicle (n = 9) and RTA 408-treated rat (n = 9). (F) Bar chart summarizing mean SEM seizure probability across time; **P 5 0.01 probabilities of seizure free days were compared using Mann-Whitney U-test. (G) Seizure duration distribution for the same animals as in C, demonstrating no significant difference between vehicle or RTA408 treated animals. KA = kainic acid.

    Article Snippet: One week or 15 weeks post kainic acid-induced status epilepticus, rats were perfused transcardially under terminal anaesthesia (pentobarbital sodium) with PBS (8 IU/ml), followed by 4% paraformaldehyde (PFA) in PBS (Santa Cruz Biotechnology).

    Techniques: Activity Assay, Control, Saline, MANN-WHITNEY

    ( a ) Representative spinal cord sections from therapeutically treated EAE mice stained for NFH (red), SMI-32 (green), scale bar = 50 μm. ( b ) Quantification of SMI-32 signal intensity relative to NFH from. ( c ) Representative EM images from three-dimensional reconstructed blocks showing degenerating axons from vehicle-treated EAE mice, and sections from KPT-350 mice depicting intact axons with no myelin, and intact axons with split myelin lamellae, (* indicates intra-lamellar myelin debris); scale bar = 1.0 μm. ( d ) Quantification from 3D-EM data sets of axons undergoing Wallerian degeneration normalized to total axons. ( e ) Quantification from 3D-EM data sets of total axons per mm 2 . ( f ) Pie graphs representing the relative degree of cytoskeletal damage in axons from vehicle, KPT-276 or KPT-350 treated mice. Healthy axons were defined by 100% cytoskeletal arrangement. Axonal damage was then quantified based on the percentage of cytoskeletal disruption with 25% or 50% disruption as indicated by an absent, fragmented or aberrantly oriented cytoskeleton; 100% disruption when only a disrupted, or flocculent cytoskeleton were detected. At least 200 axons were counted per treatment group and at least n = 2 mice per group; scale bar = 0.1 μm. ( g ) Schematic diagram of in vivo kainic acid-induced neurotoxicity in mice. Representative confocal images of CA3 region of in vivo mouse hippocampus from mice treated with either vehicle or KPT-350 (7.5 mg/kg) for 1 hr followed by injection with kainic acid (2 mg/kg) for 18 hr. Coronal brain slices of hippocampus were stained with NFH (red), SMI-32 (green), DAPI (blue); scale bar = 100 μm. ( h ) Quantification of SMI-32 intensity. Values represent mean pixel intensity ± SEM of n=2 animals per group, from two independent experiments. ( i ) Representative IBA1 + (green) stained sections of hippocampus, sections were counterstained with DAPI (blue); scale bar = 100 μm. ( j ) Quantification of ( i ). Bar graphs represent mean ± SEM. Statistical differences in: ( b ), ( h ), and ( j ) were determined using one-way ANOVA with Tukey's correction (**p < 0.01 vs. vehicle, ***p < 0.001 vs kainic acid); ( d ), ( e ) Kruskall-Wallis tests with Dunn's correction (*p < 0.05 vs. vehicle-treated controls, n=3 animals per group).

    Journal: Nature neuroscience

    Article Title: Selective inhibitors of nuclear export avert progression in preclinical models of inflammatory demyelination

    doi: 10.1038/nn.3953

    Figure Lengend Snippet: ( a ) Representative spinal cord sections from therapeutically treated EAE mice stained for NFH (red), SMI-32 (green), scale bar = 50 μm. ( b ) Quantification of SMI-32 signal intensity relative to NFH from. ( c ) Representative EM images from three-dimensional reconstructed blocks showing degenerating axons from vehicle-treated EAE mice, and sections from KPT-350 mice depicting intact axons with no myelin, and intact axons with split myelin lamellae, (* indicates intra-lamellar myelin debris); scale bar = 1.0 μm. ( d ) Quantification from 3D-EM data sets of axons undergoing Wallerian degeneration normalized to total axons. ( e ) Quantification from 3D-EM data sets of total axons per mm 2 . ( f ) Pie graphs representing the relative degree of cytoskeletal damage in axons from vehicle, KPT-276 or KPT-350 treated mice. Healthy axons were defined by 100% cytoskeletal arrangement. Axonal damage was then quantified based on the percentage of cytoskeletal disruption with 25% or 50% disruption as indicated by an absent, fragmented or aberrantly oriented cytoskeleton; 100% disruption when only a disrupted, or flocculent cytoskeleton were detected. At least 200 axons were counted per treatment group and at least n = 2 mice per group; scale bar = 0.1 μm. ( g ) Schematic diagram of in vivo kainic acid-induced neurotoxicity in mice. Representative confocal images of CA3 region of in vivo mouse hippocampus from mice treated with either vehicle or KPT-350 (7.5 mg/kg) for 1 hr followed by injection with kainic acid (2 mg/kg) for 18 hr. Coronal brain slices of hippocampus were stained with NFH (red), SMI-32 (green), DAPI (blue); scale bar = 100 μm. ( h ) Quantification of SMI-32 intensity. Values represent mean pixel intensity ± SEM of n=2 animals per group, from two independent experiments. ( i ) Representative IBA1 + (green) stained sections of hippocampus, sections were counterstained with DAPI (blue); scale bar = 100 μm. ( j ) Quantification of ( i ). Bar graphs represent mean ± SEM. Statistical differences in: ( b ), ( h ), and ( j ) were determined using one-way ANOVA with Tukey's correction (**p < 0.01 vs. vehicle, ***p < 0.001 vs kainic acid); ( d ), ( e ) Kruskall-Wallis tests with Dunn's correction (*p < 0.05 vs. vehicle-treated controls, n=3 animals per group).

    Article Snippet: After two days, infected neurons were identified by GFP fluorescence on a live imaging microscope, and then cells were treated with 5 μM kainic acid for 2 h. Following kainic acid treatment, cells were fixed with 4% PFA, and stained with antibodies for CRM1 (1:200, Santa Cruz, cat no: sc-5595), NFH (1:400, Millipore, cat no: MAB5448), SMI-32 (1:5000, Millipore, cat no: NE1023).

    Techniques: Staining, Disruption, In Vivo, Injection

    ( a ). Representative low and high magnification images of rat hippocampal neurons treated with glutamate (50 μM) and TNFα (200 ng/mL) for 4 hr and stained with neurofilament NFH (red) to identify neuronal processes and SMI-32 (green) to detect damaged neurons with localized swellings. Scale bar = 25μm for low magnification and 15 μm for high magnification ( b ) Quantification of focal axonal damage expressed as percentage of neuronal processes with beading as shown in ( a ), n = 10 neurites per field, 10 fields per experiment, three independent biological replicates. ( c ) Representative confocal images of neurons infected with either control or Xpo1 knockdown lentiviral particles. Xpo1 knockdown was confirmed by staining for CRM1 (blue). Focal axonal damage was evaluated by staining neuronal cultures with neurofilament NFH (red) to identify neuronal processes and SMI-32 (green) to detect damaged neurites in neuronal cultures treated kainic acid. Scale bar = 25 μm for low magnification and 5 μm for high magnification ( d ) Representative still images of mitochondria from videos of cultured neurons stained with the live MitoTracker® Green FM dye; scale bar = 25 μm. ( e ) Quantification of mitochondrial velocity from ( d ), n = > 10 mitochondria per condition in three independent biological replicates. ( f ) Quantification of mitochondrial length from ( d ), n = 150 mitochondria per condition, from three independent experiments. Bar graphs represent mean pixel intensity ± SEM. Statistical significance in: ( b ) was determined using one-way ANOVA with Tukey's test (***p < 0.001 vs. Glut+TNFα) ( e ), ( f ) were determined using one-way ANOVA with Dunnett's correction (*p < 0.05, ***p < 0.001 vs. control).

    Journal: Nature neuroscience

    Article Title: Selective inhibitors of nuclear export avert progression in preclinical models of inflammatory demyelination

    doi: 10.1038/nn.3953

    Figure Lengend Snippet: ( a ). Representative low and high magnification images of rat hippocampal neurons treated with glutamate (50 μM) and TNFα (200 ng/mL) for 4 hr and stained with neurofilament NFH (red) to identify neuronal processes and SMI-32 (green) to detect damaged neurons with localized swellings. Scale bar = 25μm for low magnification and 15 μm for high magnification ( b ) Quantification of focal axonal damage expressed as percentage of neuronal processes with beading as shown in ( a ), n = 10 neurites per field, 10 fields per experiment, three independent biological replicates. ( c ) Representative confocal images of neurons infected with either control or Xpo1 knockdown lentiviral particles. Xpo1 knockdown was confirmed by staining for CRM1 (blue). Focal axonal damage was evaluated by staining neuronal cultures with neurofilament NFH (red) to identify neuronal processes and SMI-32 (green) to detect damaged neurites in neuronal cultures treated kainic acid. Scale bar = 25 μm for low magnification and 5 μm for high magnification ( d ) Representative still images of mitochondria from videos of cultured neurons stained with the live MitoTracker® Green FM dye; scale bar = 25 μm. ( e ) Quantification of mitochondrial velocity from ( d ), n = > 10 mitochondria per condition in three independent biological replicates. ( f ) Quantification of mitochondrial length from ( d ), n = 150 mitochondria per condition, from three independent experiments. Bar graphs represent mean pixel intensity ± SEM. Statistical significance in: ( b ) was determined using one-way ANOVA with Tukey's test (***p < 0.001 vs. Glut+TNFα) ( e ), ( f ) were determined using one-way ANOVA with Dunnett's correction (*p < 0.05, ***p < 0.001 vs. control).

    Article Snippet: After two days, infected neurons were identified by GFP fluorescence on a live imaging microscope, and then cells were treated with 5 μM kainic acid for 2 h. Following kainic acid treatment, cells were fixed with 4% PFA, and stained with antibodies for CRM1 (1:200, Santa Cruz, cat no: sc-5595), NFH (1:400, Millipore, cat no: MAB5448), SMI-32 (1:5000, Millipore, cat no: NE1023).

    Techniques: Staining, Infection, Control, Knockdown, Cell Culture